Health Canada grants approval of the Eye-Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) for use in tracking disease progression in people living with MS
More than 90,000 Canadians live with multiple sclerosis (MS), a neurodegenerative, chronic condition that affects the central nervous system